CORC

在结果中检索

CORC

浏览/检索结果: 共21条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Outcomes by hypomagnesemia (hypomag) in the randomized phase III ASPECCT trial of patients (pts) with chemofractory wild-type (WT) ERAS exon 2 metastatic colorectal cancer (mCRC) 期刊论文
Journal of Clinical Oncology, 2016, 卷号: 34
作者:  Peeters M., Kim T.W., Li J., Cascinu S., Ruff P., Venkatasatya A., Thomas S.A., Tjulandin S., Guan X., Hoang T., Hei Y.J., Price T.J.
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
Efficacy of panitumumab (pmab) vs. cetuximab (cmab) in patients (pts) with wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC) treated with prior bevacizumab (bev): Results from ASPECCT 期刊论文
Journal of Clinical Oncology, 2016, 卷号: 34
作者:  Peeters M., Kim T.W., Li J., Cascinu S., Ruff P., Suresh A.V., Thomas A., Tjulandin S., Guan X., Hoang T., Hei Y.J., Price T.J.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Efficacy of panitumumab vs cetuximab in patients with wildtype KRAS exon 2 metastatic colorectal cancer treated with prior bevacizumab: Results from ASPECCT 期刊论文
Journal of Clinical Oncology, 2016
作者:  Peeters M., Kim T.W., Li J., Cascinu S., Ruff P., Suresh A.V., Thomas A., Tjulandin S., Guan X., Price T.J.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Outcomes by hypomagnesemia in the randomized phase III ASPECCT trial in patients with chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer (mCRC) 期刊论文
Journal of Clinical Oncology, 2016
作者:  Price T.J., Kim T.W., Li J., Cascinu S., Ruff P., Suresh A.V., Thomas A., Tjulandin S., Guan X., Peeters M.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/13
Final results from ASPECCT: Randomized phase 3 non-inferiority study of panitumumab (pmab) vs cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC) 期刊论文
Journal of Clinical Oncology, 2015, 卷号: 33
作者:  Price T.J., Peeters M., Kim T.W., Li J., Cascinu S., Ruff P., Suresh A.V., Thomas A.L., Tjulandin S., Zhang K., Sidhu R., Murugappan S.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19
Prevalence and outcomes of patients (pts) with EGFR S492R ectodomain mutations in ASPECCT: Panitumumab (pmab) vs. cetuximab (cmab) in pts with chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer (mCRC) 期刊论文
Journal of Clinical Oncology, 2015, 卷号: 33
作者:  Price T.J., Newhall K., Peeters M., Won T.K., Li J., Cascinu S., Ruff P., Suresh A.V., Thomas A., Tjulandin S., Boedigheimer M., Zhang K., Sidhu R., Murugappan S.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19
Randomized phase III study of panitumumab (pmab) vs. cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC): Outcomes by hypomagnesemia (hypomag) in ASPECCT 期刊论文
Journal of Clinical Oncology, 2015, 卷号: 33
作者:  Price T.J., Peeters M., Kim T.W., Li J., Cascinu S., Ruff P., Suresh A.V., Thomas A., Tjulandin S., Zhang K., Sidhu R., Murugappan S.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19
Prevalence and outcomes of patients (pts) with EGFR S492R ectodomain mutations in ASPECCT: Panitumumab (pmab) vs cetuximab (cmab) in pts with chemorefractory wild-type-KRAS exon 2 metastatic colorectal cancer (mCRC) 期刊论文
Journal of Clinical Oncology, 2015, 卷号: 33
作者:  Price T.J., Newhall K., Peeters M., Kim T.W., Li J., Cascinu S., Ruff P., Suresh A.V., Thomas A.L., Tjulandin S., Boedigheimer M., Zhang K., Sidhu R., Murugappan S.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19
Randomized phase 3 study of panitumumab (pmab) vs cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC): Outcomes by hypomagnesemia (hypomag) in ASPECCT 期刊论文
Journal of Clinical Oncology, 2015, 卷号: 33
作者:  Peeters M., Price T.J., Kim T.W., Li J., Cascinu S., Ruff P., Suresh A.V., Thomas A.L., Tjulandin S., Zhang K., Sidhu R., Murugappan S.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19
Randomized phase 3 study of panitumumab (pmab) vs cetuximab (cmab) in chemorefractory wildtype (WT) KRAS exon 2 metastatic colorectal cancer (mCRC): Outcomes by hypomagnesemia (hypomag) in ASPECCT 期刊论文
Journal of Clinical Oncology, 2015, 卷号: 33
作者:  Peeters M., Price T.J., Kim T.W., Li J., Cascinu S., Ruff P., Suresh A.V., Thomas A.L., Tjulandin S., Zhang K., Sidhu R., Murugappan S.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace